Protocol Page


	Study ID (Protocol Number)
	CA220-007


	STUDY LOCATIONS*
	H. Lee Moffitt Cancer Center & Research Inst, Inc Tampa, FL 33612 Recruiting	Md Anderson Can Cnt Houston, TX 77030-4009 Recruiting
	Indiana University Melvin And Bren Simon Cancer Center Indianapolis, IN 46202 Recruiting	Oncology Research Associates, Pllc D/B/A Scottsdale, AZ 85258 Recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma
	STUDY OVERVIEW
	The purpose of this study is to determine whether the combination of interleukin-21 (IL-21) and Ipilimumab in subjects with melanoma is safe, and provide preliminary information on the clinical benefits of the combination compared with Ipilimumab alone

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.